Almirall, S.A. (ALMRY)

Market Cap	2.54B
Revenue (ttm)	1.24B
Net Income (ttm)	25.06M
Shares Out	n/a
EPS (ttm)	0.12
PE Ratio	101.35
Forward PE	29.61
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Average Volume	187
Open	10.56
Previous Close	9.68
Day's Range	10.56 - 10.56
52-Week Range	9.23 - 10.56
Beta	0.39
RSI	64.41
Earnings Date	Jul 25, 2025

About Almirall

Almirall, S.A. operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising Psoriasis, atopic dermatitis, acne, actinic keratosis, onychomycosis, androgenic alopecia, oncodermatology, and orphan indications, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, nervous, and respiratory system; dermatologicals; genito urinary system and sex hormones; immun...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1943
• Employees: 2,026
• Stock Exchange: OTCMKTS
• Ticker Symbol: ALMRY

Financial Performance

Financial numbers in EUR